Literature DB >> 10408545

An analysis of the costs of ischemic stroke in an Italian stroke unit.

A Mamoli1, B Censori, L Casto, C Sileo, B Cesana, M Camerlingo.   

Abstract

OBJECTIVE: To determine the direct costs of hospital care of acute ischemic stroke in a large Italian hospital, and to identify the main components of such costs.
BACKGROUND: Cost containment in stroke care requires an up-to-date assessment of expenditures in the different areas of stroke management. However, costs may vary among countries because of different health system organizations.
METHODS: All patients with ischemic stroke admitted during 1996 were considered. Total cost was the sum of a daily component, reflecting personnel wages and general care, and an ancillary component, reflecting mostly investigations and treatments. The real costs were used, not fixed charges.
RESULTS: We included 245 patients, with a mean length of stay (LOS) of 13.1+/-7.0 days, and an in-hospital case fatality rate of 8.2%. The mean total cost per patient was 5,087,000+/-2,536,000 Italian Lira (LIT; $3,289+/-$1,640), with a mean cost per day of 388,000 LIT ($251). Approximately 80% of total costs were due to the daily component and 20% to the ancillary component. A multiple linear regression model of length of stay, which determines the daily cost, showed that the Rankin score at entry, the clinical syndrome type, and the destination at discharge independently contributed to LOS. A second linear regression model showed that younger age and longer LOS significantly increased ancillary costs.
CONCLUSIONS: The containment of hospital costs of ischemic stroke may be achieved mostly through measures that reduce LOS, such as effective treatments and a quicker deployment.

Entities:  

Mesh:

Year:  1999        PMID: 10408545     DOI: 10.1212/wnl.53.1.112

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Modelling the short term consequences of smoking cessation in England on the hospitalisation rates for acute myocardial infarction and stroke.

Authors:  B Naidoo; W Stevens; K McPherson
Journal:  Tob Control       Date:  2000-12       Impact factor: 7.552

2.  Evaluation of costs and outcome in cardioembolic stroke or TIA.

Authors:  Yaroslav Winter; Caroline Wolfram; Matthias Schaeg; Jens-Peter Reese; Wolfgang H Oertel; Richard Dodel; Tobias Back
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

3.  Dexmedetomidine versus midazolam and propofol for sedation in critically ill patients: Mining the Medical Information Mart for Intensive Care data.

Authors:  Yiyan Song; Shaowei Gao; Wulin Tan; Zeting Qiu; Huaqiang Zhou; Yue Zhao
Journal:  Ann Transl Med       Date:  2019-05

4.  Itemized hospital charges for acute cerebral infarction patients influenced by severity in an academic medical center in Korea.

Authors:  Sung Sang Yoon; Hyejung Chang; Young Dae Kwon
Journal:  J Clin Neurol       Date:  2012-03-31       Impact factor: 3.077

5.  Costs structure of the inpatient ischemic stroke treatment using an exact costing method.

Authors:  Anne Puumalainen; Outi Elonheimo; Mats Brommels
Journal:  Heliyon       Date:  2020-06-23

Review 6.  The economic burden of stroke: a systematic review of cost of illness studies.

Authors:  Stefan Strilciuc; Diana Alecsandra Grad; Constantin Radu; Diana Chira; Adina Stan; Marius Ungureanu; Adrian Gheorghe; Fior-Dafin Muresanu
Journal:  J Med Life       Date:  2021 Sep-Oct
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.